Results 61 to 70 of about 1,572 (142)

The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis

open access: yesTransplant Infectious Disease, Volume 27, Issue 6, November/December 2025.
This single‐center retrospective cohort study on 300 allogeneic hematopoietic stem cell transplant recipients from January 2017 to May 2020, in which posaconazole modified release was the most common primary antifungal prophylaxis, demonstrated a breakthrough invasive fungal disease (bIFD) rate of 9%, with associated significant all‐cause mortality at ...
Shio Yen Tio   +7 more
wiley   +1 more source

An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor

open access: yesCase Reports in Pathology, 2019
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy arising from precursors of plasmacytoid dendritic cells that represent less than 1% of hematological malignancies.
Daniel M. Pak, Maria S. Tretiakova
doaj   +1 more source

Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm

open access: yesHematology Reports, 2014
Blastic plasmacytoid dendritic cell neoplasm is a rare, aggressive tumor characterized by skin and/or marrow infiltration by CD4+ CD56+ cells. Historically, the tumor was variably thought to arise from either monocytes, T cells or NK cells giving rise to
Anand Lokare   +7 more
doaj   +1 more source

Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous involvement in a 25 years male patient: Unusual presentation of a rare entity

open access: yesIndian Journal of Pathology and Microbiology, 2015
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive neoplasm classified under "acute myeloid leukemia (AML) and related precursor neoplasm" by current WHO classification.
Sumaira Qayoom   +3 more
doaj   +1 more source

Toward immunoprofiling in MDS: A computational study of the bone marrow immune microenvironment

open access: yes
Cytometry Part B: Clinical Cytometry, Volume 108, Issue 6, Page 466-470, November 2025.
Margot F. van Spronsen   +6 more
wiley   +1 more source

Dermatoscopic features of blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia
Blastic plasmacytoid dendritic cell neoplasm is a malignant, aggressive, and rare tumor arising from plasmacytoid dendritic cell precursors. Because of its infrequency, information on clinical features and best treatment options is still lacking ...
Daniel Argüello-Ruiz   +2 more
doaj  

Pseudo-Rosette-Forming Blastic Plasmacytoid Dendritic Cell Neoplasm

open access: yesTurkish Journal of Hematology, 2020
Praveen Sharma, Shano Naseem
doaj   +1 more source

A new palliative treatment for blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature

open access: yesJournal of International Medical Research, 2019
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy that derives from plasmacytoid dendritic cells. The cancer is characterized by aggressive development and dismal prognosis, and due to limited prospective study ...
Yunning Yang   +5 more
doaj   +1 more source

Localized skin‐limited blastic plasmacytoid dendritic cell neoplasm

open access: yeseJHaem, 2022
Edwin U. Suárez   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy